Health Minister Patty Hajdu signed an order Nov. 27 to limit bulk exports of prescription drugs, saying it will help protect Canada’s drug supply. The U.S. rule to allow drug importation is set to take effect Nov. 30.
The Canadian government has said it won’t comply with the U.S. rule if it causes or worsens drug shortages, NPR reported. Canada may require drugmakers to first assess the potential for shortages before they sell to the U.S.
Ms. Hajdu didn’t name any specific drugs to be blocked, and a Health Canada spokesperson told NPR the order will only apply to drug categories subject to shortage reporting, not over-the-counter drugs.
Read the full article here.
More articles on pharmacy:
CVS Pharmacy taps new president, Neela Montgomery
White House releases 2 new drug-pricing rules
Merck to acquire COVID-19 drug developer for $425M
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
